|
Bio*One takes US$10m stake in Nasdaq firm
EDB reports an outstanding year of growth and quality investments in 2007
MerLion Pharmaceuticals Wins Prestigious Pharmaceutical Industry Scrip Award
QIAGEN and Bio*One Capital Enter into Joint Venture to Develop Molecular Diagnostics Products
|
